Generale de Sante SA (GDSF.PA)

GDSF.PA on Paris Stock Exchange

14.88EUR
11:35am EST
Price Change (% chg)

€-0.12 (-0.80%)
Prev Close
€15.00
Open
€15.00
Day's High
€15.00
Day's Low
€14.53
Volume
306
Avg. Vol
51,157
52-wk High
€16.44
52-wk Low
€11.24

GDSF.PA

Chart for GDSF.PA

About

Generale de Sante SA (GDS) is a France-based company engaged in the provision of private hospital healthcare services. The Company offers a range of hospital services and, in partnership with independent medical specialists, delivers a spectrum of care services, including oncology and radiation therapy; care for alcohol abuse... (more)
No analyst recommendations are available for GDSF.PA.

Overall

Beta: 0.48
Market Cap (Mil.): €846.41
Shares Outstanding (Mil.): 56.43
Dividend: 1.40
Yield (%): 11.83

Financials

  GDSF.PA Industry Sector
P/E (TTM): 7.92 26.17 38.47
EPS (TTM): 1.89 -- --
ROI: 11.86 7.70 18.25
ROE: 27.37 11.94 19.13
Search Stocks

BRIEF-Generale de Sante Q3 revenue 380.3 mln euros versus 417 million last year

* Q3 revenue 380.3 million euros versus 417 million euros last year

05 Nov 2014

BRIEF-Ramsay Health Care Limited and Predica launch tender offer for Generale De Sante shares

* Ramsay Health Care Limited and Predica launch simplified public tender offer for Generale De Sante shares at eur 16 per share

30 Oct 2014

BRIEF-Ramsay Health Care and Credit Agricole Assurances acquire Generale de Sante

* Says Ramsay Health Care and Credit Agricole Assurances, a subsidiary of Credit Agricole, acquired a majority stake in Generale de Sante

02 Oct 2014

Bankers ready $4.4 billion debt for healthcare acquisitions

LONDON - Bankers are lining up two separate debt financing packages worth a combined total of 3.2 billion euros ($4.36 billion) to back the acquisitions of healthcare firms Quiron and Generale de Sante, banking sources said on Wednesday.

09 Jul 2014

RLPC-Bankers ready $4.4bn debt for healthcare acquisitions

LONDON, July 9 - Bankers are lining up two separate debt financing packages worth a combined total of 3.2 billion euros ($4.36 billion) to back the acquisitions of healthcare firms Quiron and Generale de Sante, banking sources said on Wednesday.

09 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks